Biguanide chitosan microneedles with cell-free DNA scavenging ability for psoriasis therapy
Open Access
- 1 March 2024
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 33, 497-505
Abstract
High levels of cell-free DNA (cfDNA) induce psoriasis. Currently, the treatment of psoriasis has the disadvantages of penetration difficulty, suppression of normal immunity, and skin irritation. In this study, biguanide chitosan microneedles (BGC-MNs) were prepared to treat psoriasis by removing cfDNA from the dermis through the skin barrier. The effects of chitosan with different bisguanidine contents on DNA-binding capacity, biocompatibility, and inflammation inhibition were compared, revealing that chitosan containing 20% bisguanidine (BGC2) was found to have the best overall performance. In vitro, BGC2 effectively cleared cfDNA and inhibited the production of inflammatory factors. BGC-MN made from BGC2 had good mechanical and solubility properties. In vivo, BGC-MNs cleared cfDNA, reduced the level of inflammatory factors in the dermis, and exerted a good therapeutic effect on mice with psoriasis. These results suggested that BGC-MNs provided a new approach to treating psoriasis in terms of scavenging cfDNA and exerting anti-inflammatory effects.Keywords
Funding Information
- National Natural Science Foundation of China (22122501, 52073013, 52161145410, 52221006)
- Chinese Academy of Medical Sciences
- National Key Research and Development Program of China (2021YFB3800900)
This publication has 31 references indexed in Scilit:
- TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasisEuropean Journal of Immunology, 2013
- Cellular uptake of DNA–chitosan nanoparticles: The role of clathrin- and caveolae-mediated pathwaysInternational Journal of Biological Macromolecules, 2012
- Nucleic acid-binding polymers as anti-inflammatory agentsProceedings of the National Academy of Sciences, 2011
- Vitamin D and innate immunityDermatologic Therapy, 2010
- PsoriasisNew England Journal of Medicine, 2009
- Translating Molecular Insights in Autoimmunity into Effective TherapyAnnual Review of Immunology, 2009
- Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptideNature, 2007
- Pathogenesis and clinical features of psoriasisThe Lancet, 2007
- Pathogenesis and therapy of psoriasisNature, 2007
- Expression and Modulation of LL-37 in Normal Human Keratinocytes, HaCaT cells, and Inflammatory Skin DiseasesJournal of Korean Medical Science, 2005